KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Working Capital (2022 - 2023)

Ginkgo Bioworks Holdings (DNA) has disclosed Change in Working Capital for 2 consecutive years, with $4.7 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Change in Working Capital rose 76.52% year-over-year to $4.7 million, compared with a TTM value of $18.6 million through Jun 2023, changed N/A, and an annual FY2022 reading of $10.8 million, changed N/A over the prior year.
  • Change in Working Capital was $4.7 million for Q2 2023 at Ginkgo Bioworks Holdings, down from $8.5 million in the prior quarter.
  • Across five years, Change in Working Capital topped out at $8.5 million in Q1 2023 and bottomed at $2.7 million in Q1 2022.